Overview

Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This study looks at the improvements in signs and symptoms in patients with inflammation of the lids, blepharitis, using two different FDA approved topical antibiotic agents, Besifloxocin and Erythromycin. It also evaluates the bacterial cultures in these patients for microbiologic evidence of improvement.
Phase:
Phase 4
Details
Lead Sponsor:
John, George, M.D.
Collaborator:
Bausch & Lomb Incorporated
Treatments:
Besifloxacin
Erythromycin
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate